TNF and rheumatoid arthritis: RADIATE and TOWARD demonstrated the efficacy and safety of TCZ in patients with RA who had an inadequate response or intolerance to one or more TNF inhibitors (29) and also to conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) (30).